Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1745-6215
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial ; volume:22 ; number:1 ; day:4 ; month:11 ; year:2021 ; pages:1-4 ; date:12.2021
Trials ; 22, Heft 1 (4.11.2021), 1-4, 12.2021

Urheber
Privé, Bastiaan M.
Janssen, Marcel J. R.
Oort, Inge M. van
Muselaers, Constantijn H. J.
Jonker, Marianne A.
Gemert, Willemijn A. van
Groot, Michel de
Westdorp, Harm
Mehra, Niven
Verzijlbergen, J. Fred
Scheenen, Tom W. J.
Zámecnik, Patrik
Barentsz, Jelle O.
Gotthardt, Martin
Noordzij, Walter
Vogel, Wouter V.
Bergman, Andries M.
Poel, Henk G. van der
Vis, André N.
Oprea-Lager, Daniela E.
Gerritsen, Winald R.
Witjes, J. Alfred
Nagarajah, James
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13063-021-05733-4
URN
urn:nbn:de:101:1-2022011818234185987475
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:23 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Privé, Bastiaan M.
  • Janssen, Marcel J. R.
  • Oort, Inge M. van
  • Muselaers, Constantijn H. J.
  • Jonker, Marianne A.
  • Gemert, Willemijn A. van
  • Groot, Michel de
  • Westdorp, Harm
  • Mehra, Niven
  • Verzijlbergen, J. Fred
  • Scheenen, Tom W. J.
  • Zámecnik, Patrik
  • Barentsz, Jelle O.
  • Gotthardt, Martin
  • Noordzij, Walter
  • Vogel, Wouter V.
  • Bergman, Andries M.
  • Poel, Henk G. van der
  • Vis, André N.
  • Oprea-Lager, Daniela E.
  • Gerritsen, Winald R.
  • Witjes, J. Alfred
  • Nagarajah, James
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Oligometastatic Prostate Cancer

Oligometastatic Prostate Cancer

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Verbundene Objekte